In our weekly check, Twist Bioscience Corporation is graded C (A to F). Of 17 checks on debt, profit, cash flow and trend: 10 pass, warnings: 0, red flags: 7.
Sector: Healthcare · Diagnostics & Research
Next earnings report: 2026-11-13
TXG · TECH · IBRX · HALO · KRYS · AXSM
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.
Updated 2026-10-03